Phase 2 Clinical Trial of a Vaginal Mucosal Vaccine for Urinary Tract Infections

The Journal of Urology - Tập 170 - Trang 867-869 - 2003
DAVID T. UEHLING1, WALTER J. HOPKINS1, JOHNY E. ELKAHWAJI1, DIANNE M. SCHMIDT1, GLEN E. LEVERSON1
1From the Department of Surgery, Division of Urology, University of Wisconsin Medical School, Madison, Wisconsin

Tài liệu tham khảo

Warren, 1996, Clinical presentation and epidemiology of urinary tract infections, 3 Kunin, 1997 Kunin, 1994, Urinary tract infections in females, Clin Infect Dis, 18, 1, 10.1093/clinids/18.1.1 Foxman, 1990, Recurring urinary tract infections: incidence and risk factors, Am J Public Health, 80, 331, 10.2105/AJPH.80.3.331 Hooton, 1996, A prospective study of risk factors for symptomatic urinary tract infection in young women, N Engl J Med, 335, 468, 10.1056/NEJM199608153350703 Ronald, 2001, Urinary tract infection in adults: research priorities and strategies, Int J Antimicrob Agents, 17, 343, 10.1016/S0924-8579(01)00303-X Manges, 2001, Widespread distribution of urinary tract infections caused by a multidrug-resistant Escherichia coli clonal group, N Engl J Med, 345, 1007, 10.1056/NEJMoa011265 Sahm, 2001, Multidrug-resistant urinary tract isolates of Escherichia coli: prevalence and patient demographics in the United States in 2000, Antimicrob Agents Chemother, 45, 1402, 10.1128/AAC.45.5.1402-1406.2001 Uehling, 1982, Vaginal immunization against urinary tract infection, J Urol, 128, 1382, 10.1016/S0022-5347(17)53513-2 Uehling, 1994, Vaginal immunization of monkeys against urinary tract infection with a multi-strain vaccine, J Urol, 151, 214, 10.1016/S0022-5347(17)34919-4 Uehling, 1991, Immunization against urinary tract infection with a multi-valent vaginal vaccine, J Urol, 146, 223, 10.1016/S0022-5347(17)37756-X Uehling, 1994, Phase I clinical trial of vaginal mucosal immunization for recurrent urinary tract infection, J Urol, 152, 2308, 10.1016/S0022-5347(17)31664-6 Uehling, 2001, Vaginal mucosal immunization for recurrent urinary tract infection: extended phase II clinical trial, J Infect Dis, 183, S81, 10.1086/318839 Kruze, 1992, Protection by a polyvalent vaccine against challenge infection and pyelonephritis, Urol Res, 20, 177, 10.1007/BF00296534 Kruze, 1989, Urinary antibody response after immunisation with a vaccine against urinary tract infection, Urol Res, 17, 361, 10.1007/BF00510527 Gupta, 1998, Inverse association of H2O2-producing lactobacilli and vaginal Escherichia coli colonization in women with recurrent urinary tract infections, J Infect Dis, 178, 446, 10.1086/515635 Hopkins, 1987, Local and systemic antibody responses accompany spontaneous resolution of experimental cystitis in cynomolgus monkeys, Infect Immun, 55, 1951, 10.1128/IAI.55.9.1951-1956.1987 Gupta, 2001, Antimicrobial resistance among uropathogens that cause community-acquired urinary tract infections in women: a nationwide analysis, Clin Infect Dis, 33, 89, 10.1086/320880 Hopkins, 2002, Vaccine development for the prevention of urinary tract infections, Curr Infect Dis Rep, 4, 509, 10.1007/s11908-002-0037-8 Eden, 1976, Variable adherence to normal human urinary-tract epithelial cells of Escherichia coli strains associated with various forms of urinary-tract infection, Lancet, 1, 490, 10.1016/S0140-6736(76)90788-1 Kozlowski, 2002, Differential induction of mucosal and systemic antibody responses in women after nasal, rectal, or vaginal immunization: influence of the menstrual cycle, J Immunol, 169, 566, 10.4049/jimmunol.169.1.566